Adult ADHD Screening Test
A quick, validated screening for ADHD traits in adults.
This screening uses the ASRS v1.1 Screener β the six questions of Part A of the Adult ADHD Self-Report Scale v1.1, developed with the World Health Organization (Kessler et al., 2005). Answer for how you have felt and behaved over the past 6 months.
6 questions β takes about 1 minute
About the ASRS v1.1 ADHD Screener
The ASRS v1.1 Screener is the 6-question Part A of the Adult ADHD Self-Report Scale v1.1, developed with the World Health Organization (WHO) and the Workgroup on Adult ADHD.
The full ASRS v1.1 Symptom Checklist has 18 questions, one for each DSM-IV ADHD symptom (Kessler et al., 2005). Its authors found that six of them β four about inattention and organization, two about restlessness β predicted ADHD best, and those six became the Screener. Each question asks how often something has happened over the past 6 months, from Never to Very Often. The items were written in the DSM-IV era, and the Screener is still widely used and recommended for screening adults.
The 6-question Adult Self-Report Scale-Version1.1 (ASRS-V1.1) Screener is a subset of the 18-question Adult ADHD Self-Report Scale-Version1.1 (Adult ASRS-V1.1) Symptom Checklist. Β© New York University and President and Fellows of Harvard College.
How ASRS v1.1 Scoring Works
Each of the 6 answers is scored from 0 (Never) to 4 (Very Often), and the six scores are added up β a total from 0 to 24.
A total of 14 or more is a positive screen. This is the 0β24 scoring method Harvard described in its February 2024 scoring update, as a more robust alternative to the printed form's rule of counting answers in shaded boxes, which gave high and inconsistent prevalence estimates. Harvard also groups totals into four bands, shown below.
| 0β9 | Low negative β Few of the six symptoms happen often; the screen is negative. |
|---|---|
| 10β13 | High negative β Below the cut-off, but some symptoms happen often β this does not rule out ADHD. |
| 14β17 | Low positive β A positive screen; worth discussing with a clinician. |
| 18β24 | High positive β A clearly positive screen; an evaluation by a clinician is recommended. |
A positive screen means your answers resemble those of adults with ADHD closely enough to be worth discussing with a clinician β it is not a diagnosis. Below 14 does not rule ADHD out. In a 2007 study of US health-plan members, a total of 14 or more identified 64.9% of adults with ADHD (sensitivity) and correctly screened out 94.0% of those without it (specificity); the four-band version had an AUC of 0.90 (Kessler et al., 2007). Results differ by setting, and these are the study's figures, not this site's.
Important Disclaimers
- This is a screening tool, not a diagnostic instrument. Only a qualified healthcare professional can diagnose ADHD.
- The ASRS v1.1 Screener is designed for adults (ages 18+). It may not be appropriate for children or adolescents.
- Screening results can be affected by other conditions including anxiety, depression, sleep disorders, and thyroid conditions.
- A positive screening result should be followed up with a comprehensive clinical evaluation including developmental history review.
Frequently Asked Questions
What does a score of 14 out of 24 mean?
Can a score below 14 rule out ADHD?
Is the ASRS v1.1 the same as the ASRS-5?
Why is ADHD often missed in women?
Can ADHD coexist with anxiety or depression?
How does the ASRS v1.1 Screener compare to longer ADHD assessments?
Why do some ASRS forms use 4 out of 6 shaded boxes?
What should I do if I score above the threshold?
References
Adler, L.A., Spencer, T., Faraone, S.V., et al. (2006). Validity of Pilot Adult ADHD Self-Report Scale. Annals of Clinical Psychiatry, 18(3), 145-148.
National Institute of Mental Health. (2024). Attention-Deficit/Hyperactivity Disorder.
National Institute for Health and Care Excellence. (2019). ADHD: diagnosis and management (NICE NG87).
Medically reviewed by Holly Schiff, Psy.D., Licensed Clinical Psychologist β CT #8.003896, RI #PS02171, NY; Registered Telehealth Psychologist β FL #TPPY2749Β· Last reviewed September 20, 2026
